Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18565257rdf:typepubmed:Citationlld:pubmed
pubmed-article:18565257lifeskim:mentionsumls-concept:C0007226lld:lifeskim
pubmed-article:18565257lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:18565257lifeskim:mentionsumls-concept:C0033554lld:lifeskim
pubmed-article:18565257lifeskim:mentionsumls-concept:C0036421lld:lifeskim
pubmed-article:18565257pubmed:issue2lld:pubmed
pubmed-article:18565257pubmed:dateCreated2008-6-20lld:pubmed
pubmed-article:18565257pubmed:abstractTextSystemic sclerosis (SSc) is characterized by Raynaud's phenomenon and frequent cutaneous ulcers. In patients resistant to oral treatments, i.v. prostanoids are usefully employed. Some anecdotal reports underlined the potential risk to develop cardiovascular ischemic complications in prostanoid-treated SSc patients.lld:pubmed
pubmed-article:18565257pubmed:languageenglld:pubmed
pubmed-article:18565257pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18565257pubmed:citationSubsetIMlld:pubmed
pubmed-article:18565257pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18565257pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18565257pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18565257pubmed:statusMEDLINElld:pubmed
pubmed-article:18565257pubmed:issn0392-856Xlld:pubmed
pubmed-article:18565257pubmed:authorpubmed-author:SebastianiMMlld:pubmed
pubmed-article:18565257pubmed:authorpubmed-author:RossiRRlld:pubmed
pubmed-article:18565257pubmed:authorpubmed-author:ManfrediAAlld:pubmed
pubmed-article:18565257pubmed:authorpubmed-author:FerriCClld:pubmed
pubmed-article:18565257pubmed:authorpubmed-author:ModenaM GMGlld:pubmed
pubmed-article:18565257pubmed:authorpubmed-author:GiuggioliDDlld:pubmed
pubmed-article:18565257pubmed:authorpubmed-author:ColaciMMlld:pubmed
pubmed-article:18565257pubmed:issnTypePrintlld:pubmed
pubmed-article:18565257pubmed:volume26lld:pubmed
pubmed-article:18565257pubmed:ownerNLMlld:pubmed
pubmed-article:18565257pubmed:authorsCompleteYlld:pubmed
pubmed-article:18565257pubmed:pagination333-6lld:pubmed
pubmed-article:18565257pubmed:dateRevised2010-3-23lld:pubmed
pubmed-article:18565257pubmed:meshHeadingpubmed-meshheading:18565257...lld:pubmed
pubmed-article:18565257pubmed:meshHeadingpubmed-meshheading:18565257...lld:pubmed
pubmed-article:18565257pubmed:meshHeadingpubmed-meshheading:18565257...lld:pubmed
pubmed-article:18565257pubmed:meshHeadingpubmed-meshheading:18565257...lld:pubmed
pubmed-article:18565257pubmed:meshHeadingpubmed-meshheading:18565257...lld:pubmed
pubmed-article:18565257pubmed:meshHeadingpubmed-meshheading:18565257...lld:pubmed
pubmed-article:18565257pubmed:meshHeadingpubmed-meshheading:18565257...lld:pubmed
pubmed-article:18565257pubmed:meshHeadingpubmed-meshheading:18565257...lld:pubmed
pubmed-article:18565257pubmed:meshHeadingpubmed-meshheading:18565257...lld:pubmed
pubmed-article:18565257pubmed:meshHeadingpubmed-meshheading:18565257...lld:pubmed
pubmed-article:18565257pubmed:meshHeadingpubmed-meshheading:18565257...lld:pubmed
pubmed-article:18565257pubmed:meshHeadingpubmed-meshheading:18565257...lld:pubmed
pubmed-article:18565257pubmed:meshHeadingpubmed-meshheading:18565257...lld:pubmed
pubmed-article:18565257pubmed:meshHeadingpubmed-meshheading:18565257...lld:pubmed
pubmed-article:18565257pubmed:meshHeadingpubmed-meshheading:18565257...lld:pubmed
pubmed-article:18565257pubmed:articleTitleCardiovascular risk and prostanoids in systemic sclerosis.lld:pubmed
pubmed-article:18565257pubmed:affiliationChair and Rheumatology Unit, University of Modena e Reggio Emilia, Medical School; Policlinico di Modena, Modena, Italy.lld:pubmed
pubmed-article:18565257pubmed:publicationTypeJournal Articlelld:pubmed